Literature DB >> 30572400

[Chinese guidelines for the diagnosis and treatment of pulmonary hypertension 2018].

.   

Abstract

Entities:  

Year:  2018        PMID： 30572400     DOI： 10.3760/cma.j.issn.0253-3758.2018.12.006

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN： 0253-3758


× No keyword cloud information.
  5 in total

1.  Effect of hepatocyte growth factor on mice with hypoxic pulmonary arterial hypertension: a preliminary study.

Authors:  Hu-Ting Tang; Wei-Hao Mu; Yu-Jing Xiang; Yong An
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-08-15

2.  miR-125a-5p inhibits glycolysis by targeting hexokinase-II to improve pulmonary arterial hypertension.

Authors:  Li Luo; Lusheng Xiao; Guili Lian; Huajun Wang; Liangdi Xie
Journal:  Aging (Albany NY)       Date:  2020-05-19       Impact factor: 5.682

3.  The era of clinical application of gene diagnosis in cardiovascular diseases is coming.

Authors:  Yu-Bao Zou; Ru-Tai Hui; Lei Song
Journal:  Chronic Dis Transl Med       Date:  2020-01-17

4.  [Dasatinib-related pulmonary adverse events in patients with chronic myeloid leukemia].

Authors:  S Yang; Y Z Qin; Y Y Lai; H X Shi; Y Hou; X J Huang; Q Jiang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-12-14

5.  Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial.

Authors:  Qin-Hua Zhao; Su-Gang Gong; Jing He; Ping Yuan; Wen-Hui Wu; Ci-Jun Luo; Rong Jiang; Rui Zhang; Hong-Ling Qiu; Hui-Ting Li; Yuan Li; Jin-Ming Liu; Lan Wang
Journal:  Trials       Date:  2021-12-27       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.